The 5 Secrets Canadian Web Pharmacies Don't Want You To Know
#1: What's the difference between a Canadian retail pharmacy you can drive to over the border and a "Canadian online pharmacy" sending medicine in the mail? Click here to learn the secret.
#2: Does the medicine from a "Canadian online pharmacy" REALLY come from Canada and other safe countries? Learn where it really comes from.
#3: What's the REAL secret behind the rock-bottom prices that Canadian online pharmacies provide? Click here to find out.
#4: Who really protects consumers from fake medicines purchased from a Canadian online pharmacy? Learn who your protector is.
#5: Isn't the medicine I get from a "Canadian online pharmacy" just from the pile of medications that are price-fixed by the Canadian government? Learn the real source of those Canadian drugs.
Featured Story
Click on the image to download the flyer.
Rx360 Launches Physician Education Campaign on the Risks of Counterfeit Drug Wholesalers
Rx360 has launched a new campaign educating healthcare providers to the risks of buying diverted and suspect products advertised directly to doctors' offices via fax blast, direct email and online marketing.
Lewis T. Kontnik, team lead for the education campaign, says, "Some of the recent problems with counterfeit and diverted medicines in the US, including the counterfeit versions of Avastin, resulted in part from a lack of awareness by physicians and medical practice administrators of the risks of counterfeit and diverted medicines. The ads of the professional diverters can appear tempting when they promise 'genuine' medicine and substantial discounts, however the facts are different and the consequences can be very serious."
Kontnik points to the FDA's warning about counterfeit Avastin or Altuzan which were sold directly to physicians by foreign distributors through US middlemen.
"The 'Protect Your Patients—Know Your Supplier' flyer is designed to help healthcare providers and administrators who purchase and dispense medicine better understand the risks of counterfeit and diverted medicine. It also teaches them to identify suspicious offers in order to only buy medicines in a safe manner.
The flyer provides information about how to report suspicious activity, such as suspected counterfeiting, and explains the risks to doctors for using unapproved medication. The consequences are very serious. Patient safety can be threatened by products of unknown origin, as they have in the past. Patients who received counterfeit medications have sickened and even died because the medications contained the wrong ingredients, contaminated medicines or degraded drugs.
Additionally, healthcare professionals who purchase and use unapproved drug products are subject to criminal and civil liability. It is illegal under the Food, Drug and Cosmetic Act to import and use drug products unapproved by the FDA. Also billing the government or private insurance for unapproved medicines may be fraud and not covered by malpractice insurance, warns Rx-360.
Learn more about the campaign at Rx-360.org.
MORE>>>
FDA Releases Video on Counterfeit Detection Device 3 May 13, 2013
The FDA has released more information about their new counterfeit drug detection device, Counterfeit Detection Device 3 (CD-3). In this newly-released video, Nico Ranieri, the FDA research biologist who developed this new technology talks about how important such innovations are to patient safety.
In 2005, it first occurred to Nicolas Ranieri to try to use the type of ultra-violet light devices deployed in crime scene investigations in a hand-held counterfeit drug detection device. Up to that point, drug testing equipment was both delicate, expensive, and also required highly-trained scientists to perform the tests for fakes. Says Ranieri, “We wanted to find counterfeits, and we wanted to find them as fast as possible,” reports the FDA.
MORE>>>
Fake Botox on the Rise in US as FDA Warnings and Recent Arrest Indicate
May 7, 2013
In 2012, the FDA sent over 350 warning letters to doctors advising them they may have purchased fraudulent or misbranded injectable drugs, including fake versions of Avastin, Botox, and two different osteoporosis treatments. Now the FDA has identified another batch of fake Botox that is currently being marketed to doctor via fax blast.
On April 26, 2013, the US Food and Drug Administration (FDA) posted a drug safety warning for healthcare practitioners, warning them that fraudulent versions of the anti-wrinkle treatment Botox are being marketed and sold in the US. The Botox is being sold by unlicensed suppliers, and has not been vetted within the secure U.S. supply chain. They state that the FDA “cannot confirm that the manufacture, quality, storage, and handling of these products follow U.S. standards. These fraudulent products are considered unsafe and should not be used."
MORE>>>
Raid on London Apartment Finds Three Quarters of a Million Dollars in Fake Drugs
May 8, 2013
When London police raided an apartment in west London last month, they were looking for visa cheats. What they found instead was over $750,000 worth of counterfeit medications stored in deplorable conditions.
A raid by Home Office Immigration Enforcement officers in West London that was aimed at catching people who had overstayed their visas instead found a vast quantity of unlicensed prescription medications, reports the MHRA. Investigators from the MHRA believe the drugs, which were mostly ED, weight loss, and hair loss treatments, were manufactured in India. Anabolic steroids were also found in the raid.
MORE>>>
PSM Applauds INTERPOL, Industry Partnership to Combat Counterfeit Medicines
March 12, 2013
March 12, 2013 (Washington, D.C.) – The Partnership for Safe Medicines (PSM), the leading advocacy organization dedicated to fighting the spread of counterfeit drugs, applauds today’s announcement of a bold new initiative between INTERPOL and the pharmaceutical industry to combat the global health threat of counterfeit and fake medicines.
This new initiative broadens the scope of the successful Medical Product Counterfeiting and Pharmaceutical Crime Unit through the creation of a Pharmaceutical Crime Program to assist and enhance worldwide law enforcement efforts. Thomas Kubic, PSM Board Member and CEO of the Pharmaceutical Security Institute, released the following statement hailing the new agreement:
MORE>>>Counterfeit Drug Incident Encyclopedia
- London Raid Finds $750K in Misbranded Drugs: April 23, 2013
- Chicago Pharmacist Charged with Substituting Chinese Counterfeits for Genuine Medication: April 18, 2013
- 4 Welsh Residents Sentenced in UK Counterfeit Drugs Case: March 27, 2013
- Portguese National Sentenced to 44 Months in Jail after $2.4 Million Worth of Unlicensed and Class C Drugs Seized by MHRA: February 25, 2013
- Brother of Lebanese State Minister Arrested in Counterfeit Drugs Case: February 15, 2013
- 7 Sentenced in China For Producing Toxic Gel Medicine Capsules: February 6, 2013
- 3rd Instance of Counterfeit Cancer Treatment Found in United States: February 5, 2013
- Puerto Rican Man Sentenced in US Counterfeit Drugs Case: January 28, 2013
- Canadian Citizen & Online Pharmacy Entrepreneur Sentenced to 4 Years in Counterfeit Drugs Case: January 9, 2013
- Fake Doctor Pleads Guilty to Practicing Without a License & Administering Unapproved Drugs in San Diego: October 19, 2012
Counterfeit Drug And Safety Conferences
© 2002-2011 Partnership for Safe Medicines |
Contact Us |
Privacy Policy |
Editorial Staff |
RSS Feeds 
